31077-71-1 Usage
Uses
Used in Pharmaceutical Industry:
4-O-(6-Amino-6-deoxy-α-D-glucopyranosyl)-2-deoxy-D-streptamine is used as an active pharmaceutical ingredient for the development of new drugs targeting various diseases. Its unique structure allows for specific interactions with biological targets, making it a promising candidate for drug discovery and development.
Used in Research and Development:
In the field of research and development, 4-O-(6-Amino-6-deoxy-α-D-glucopyranosyl)-2-deoxy-D-streptamine serves as a valuable compound for studying the structure-activity relationships of various biologically active molecules. Its unique structural features can provide insights into the design and synthesis of novel therapeutic agents.
Used in Drug Delivery Systems:
Similar to gallotannin, 4-O-(6-Amino-6-deoxy-α-D-glucopyranosyl)-2-deoxy-D-streptamine can be employed in drug delivery systems to improve the bioavailability and therapeutic outcomes of various drugs. Its unique structural properties can be utilized to develop novel carriers and enhance the delivery of drugs to specific target sites.
Used in Chemical Synthesis:
4-O-(6-Amino-6-deoxy-α-D-glucopyranosyl)-2-deoxy-D-streptamine can also be used as a key intermediate in the synthesis of various complex organic molecules, including natural products and pharmaceuticals. Its unique structural features make it a valuable building block for the development of novel chemical entities with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 31077-71-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,0,7 and 7 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 31077-71:
(7*3)+(6*1)+(5*0)+(4*7)+(3*7)+(2*7)+(1*1)=91
91 % 10 = 1
So 31077-71-1 is a valid CAS Registry Number.
InChI:InChI=1/C12H25N3O7/c13-2-5-7(17)8(18)10(20)12(21-5)22-11-4(15)1-3(14)6(16)9(11)19/h3-12,16-20H,1-2,13-15H2/t3-,4+,5-,6+,7-,8+,9-,10-,11-,12-/m1/s1
31077-71-1Relevant academic research and scientific papers
NEW AMINOGLYCOSIDE COMPOUNDS AND DERIVATIVES THEREOF
-
Page/Page column 64-65, (2008/06/13)
New amino glycoside compounds or derivatives thereof having at least one sugar moiety and which comprise two or more cyclic structures capable of forming “charmed” structural features at physiological pH, and which have binding affinities for RNA and protein structures and may be used as therapeutic or screening or diagnostic agents and the like.
Design and synthesis of new aminoglycoside antibiotics containing neamine as an optimal core structure: Correlation of antibiotic activity with in vitro inhibition of translation
Greenberg, William A.,Priestley, E. Scott,Sears, Pamela S.,Alper, Phil B.,Rosenbohm, Christoph,Hendrix, Martin,Hung, Shang-Cheng,Wong, Chi-Huey
, p. 6527 - 6541 (2007/10/03)
The structure and activity of the pseudodisaccharide core found in aminoglycoside antibiotics was probed with a series of synthetic analogues in which the position of amino groups was varied around the glucopyranose ring. The naturally occurring structure
